SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial of GPS in AML has reached its 80-event milestone, and traders are focused on the pending topline survival results, which the company has said it expects to report in November. Many are betting on positive data and speculating about short-covering, while others warn the outcome is uncertain and question the delay as the shares have weakened.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Q3 results and raised revenue outlook are driving attention: traders are cheering the stronger forward guidance and debating whether it can support a rally or short squeeze despite a wider-than-expected loss and concerns about cash burn and margins. The reaction is split between optimism about AI demand and skepticism about the companys profitability.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation as CEO and the appointment of CFO Colette Kress as interim chief have driven NVDA attention, amid reports about Huangs relationships and speculation over possible China-related scrutiny. Traders are divided between buying the selloff on confidence in Nvidias business and upcoming earnings, and expecting further pressure from leadership uncertainty and regulatory concerns.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned BLA submission was pushed to mid-2027 as the company refines assays and addresses manufacturing consistency, sparking a sharp selloff. Traders debate whether this is a fixable manufacturing delay that leaves the Phase 3 results intact or a sign of greater regulatory and timeline risk; the expanded ATM also raised dilution concerns.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials quarterly results beat expectations and its next-quarter guidance topped consensus, but shares fell anyway. Traders are debating whether the strong report was already priced in and selling pressure reflects a broader semiconductor pullback, or whether the guidance supports a bullish longer-term view.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos quarterly earnings beat and raised full-year outlook, including stronger AI infrastructure expectations, are driving attention. Traders welcomed the results but debated the muted share-price reaction, with some calling it a sell-the-news move or profit-taking despite the stronger outlook.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nus quarterly results are driving attention: traders welcome strong revenue growth and improved efficiency, but a slight EPS miss and concerns about delinquencies and credit quality temper the reaction. The community is split on whether the growth outweighs lending risks, with some frustrated that the shares remain weak despite the broadly solid report.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXOs strong third-quarter results, margin improvements and newly authorized share-repurchase program are drawing attention, but traders are frustrated that the stock is falling despite the positive report. Some see the results and buyback as support for the long-term case, while others blame rate sensitivity and broader market pressure for the weak share reaction.

Cardinal Infrastructure Group, Inc. provides infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. It delivers wet utility installations of water, sewer, and stormwater systems, as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. The company was founded on June 12, 2025 and is headquartered in Raleigh, NC.

Cardinal Infrastructure Group Inc - Ordinary Shares - Class A

Cardinals steep selloff follows weak quarterly results, sharply lower project margins and the withdrawal of its 2026 guidance, with traders also citing project-cost overruns and the CFOs planned departure. The community is split between viewing the drop and announced buyback as an overreaction given the companys cash and backlog, and fearing deeper execution and management problems.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax shares are selling off despite a stronger revenue outlook and a Sanofi milestone, with traders focused on profitability being pushed to 2029 and the lack of a new partnership or concrete pipeline updates. Some see progress in the Sanofi and Pfizer licensing strategy, while others blame weak execution and shareholder-unfriendly management; a broader market selloff is also cited as a factor.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citizens reiterated $SPRB Market Outperform-$143. 
[DNLI RGNX RARE BMRM IVA] 
Citizens, next Wednesday (11/18) at 1:30 ET, will host Dr. Cara O&#39;Neill to discuss the unmet need in Sanfilippo syndrome type B (MPS IIIB). 
Spruce plans on submitting its BLA for its enzyme replacement therapy (TA-ERT) in December for MPS IIIB, and as such Citizens believe it&#39;s a great time to better understand the unmet need for the neurodegenerative condition with no approved therapies today.

B | RILEY on $SPRB in a note to investors said -- We reiterate our Buy rating and $160 PT on Spruce Biosciences (SPRB) after hosting a recent vNDR with CEO Javier Szwarcberg, M.D., M.P.H., and President and CFO Samir Gharib. 
$DNLI RGNX $RARE BMRN IVA 
Here&#39;s what B | RILEY went on to say: https://x.com/Quantumup1/status/2107095325932482750?s=20

B | RILEY on $SPRB in a note to investors said -- We reiterate our Buy rating and $160 PT on Spruce Biosciences (SPRB) after hosting a recent vNDR with CEO Javier Szwarcberg, M.D., M.P.H., and President and CFO Samir Gharib.$DNLI RGNX $RARE BMRN IVAB | RILEY added - Execution...

quantumup on X (formerly Twitter): "B | RILEY on $SPRB in a note to investors said -- We reiterate our Buy rating and $160 PT on Spruce Biosciences (SPRB) after hosting a recent vNDR with CEO Javier Szwarcberg, M.D., M.P.H., and President and CFO Samir...

StockTwits Web

Spruce Biosciences Inc

Denali Therapeutics Inc

Ultragenyx Pharmaceutical Inc

Quantumup

 Market Outperform-$143. 
[DNLI RGNX RARE BMRM IVA] 
Citizens, next Wednesday (11/18) at 1:30 ET, will host Dr. Cara O'Neill to discuss the unmet need in Sanfilippo syndrome type B (MPS IIIB). 
Spruce plans on submitting its BLA for its enzyme replacement therapy (TA-ERT) in December for MPS IIIB, and as such Citizens believe it's a great time to better understand the unmet need for the neurodegenerative condition with no approved therapies today.